ALLOS THERAPEUTICS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$471.5M

591 transactions

Summary

ALLOS THERAPEUTICS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $339.3MSales: $45.2M43 insiders

Date	Insider	Type	Value
2012-09-05	Joint reporting: SPECTRUM PHARMACEUTICALS INC; SAPPHIRE ACQUISITION SUB, INC.	Buy	$238.2M
2012-09-05	Joint reporting: WARBURG PINCUS & CO.; Warburg Pincus Private Equity VIII, L.P.; WARBURG PINCUS LLC; Landy Joseph P.; KAYE CHARLES R; Warburg Pincus Partners LLC	U	$47.5M
2012-09-04	BERNS PAUL L(Chief Executive Officer)	U	$2.2M
2012-09-04	Morris Charles Q(Chief Medical Officer)	U	$1.2M
2012-09-04	Graboyes Marc H(SVP, General Counsel)	U	$986K
2012-09-04	HOFFMAN STEPHEN J	U	$861K
2012-09-04	Goldsmith Bruce A(SVP, Corporate Development)	U	$631K
2012-09-04	Schick Michael E(VP, Sales and Marketing)	U	$519K
2012-09-04	Clark David C(VP, Finance)	U	$377K
2012-09-04	BENNETT BRUCE K JR(VP, Pharmaceutical Operations)	U	$270K
2012-09-04	HOFFMAN STEPHEN J	U	$167K
2012-09-04	LATTS JEFFREY	U	$100K
2012-09-04	LEFF JONATHAN S	U	$100K
2012-09-04	TURNER JOSEPH L	U	$100K
2012-09-04	STOUT DAVID M	U	$64K
2012-09-04	GONZALO CECILIA	U	$46K
2012-09-04	HOFFMAN STEPHEN J	U	$364
2012-09-04	HOFFMAN STEPHEN J	U	$364
2012-09-04	HOFFMAN STEPHEN J	U	$364
2012-09-04	HOFFMAN STEPHEN J	U	$364

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ALLOS THERAPEUTICS INC — Contributions, Lobbying & Contracts | Poliscope